KalVista Pharmaceuticals, Inc. (KALV): 4 insider purchases in the last two years; 1 trade disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Apr 11, 2025 | Venrock Healthcare Capital Partners EG, L.P. TenPercentOwner | 25,000 | $9.42 | $235.5K | no history |
| Feb 14, 2025 | VHCP Management EG, LLC TenPercentOwner | 161,700 | $9.27 | $1.5M | no history |
| Feb 11, 2025 | Venrock Healthcare Capital Partners III, L.P. TenPercentOwner | 104,489 | $9.26 | $967.1K | no history |
| Feb 3, 2025 | VHCP Management III, LLC TenPercentOwner | 70,023 | $8.88 | $621.6K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Jan 20, 2023 | Christopher L. Jacobs | purchase | $1,001 - $15,000 |